William T Johnson (William Johnson)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Hodgkin Lymphoma

Diffuse Large B Cell Lymphoma

Top Venues

Leukemia & lymphoma

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Ying Liu, Rohan Sardana, David Nemirovsky, Denise Frosina, Achim Jungbluth, William T Johnson, Santosha A Vardhana, Maria Arcila, Steven M Horwitz, Andriy Derkach, Ahmet Dogan, Wenbin Xiao
Somatic mutations in FAS pathway increase hemophagocytic lymphohistiocytosis risk in patients with T- and/or NK-cell lymphoma. Blood advances 8 (12) (2024)
Ying Liu, Rohan Sardana, David Nemirovsky, Denise Frosina, Achim Jungbluth, William T Johnson, Santosha A Vardhana, Maria Arcila, Steven M Horwitz, Andriy Derkach, Ahmet Dogan, Wenbin Xiao
Somatic mutations in FAS pathway increase hemophagocytic lymphohistiocytosis risk in patients with T- and/or NK-cell lymphoma. Blood advances 8 (12) (2024)
Ying Liu, Rohan Sardana, David Nemirovsky, Denise Frosina, Achim Jungbluth, William T Johnson, Santosha A Vardhana, Maria E Arcila, Steven M Horwitz, Andriy Derkach, Ahmet Dogan, Wenbin Xiao
Somatic mutations in FAS pathway increase hemophagocytic lymphohistiocytosis risk in T- and/or NK-cell lymphoma patients. Blood advances (2024)
Ying Liu, Rohan Sardana, David Nemirovsky, Denise Frosina, Achim Jungbluth, William T Johnson, Santosha A Vardhana, Maria Arcila, Steven M Horwitz, Andriy Derkach, Ahmet Dogan, Wenbin Xiao
Somatic mutations in FAS pathway increase hemophagocytic lymphohistiocytosis risk in patients with T- and/or NK-cell lymphoma. Blood advances 8 (12) (2024)
Ying Liu, Rohan Sardana, David Nemirovsky, Denise Frosina, Achim Jungbluth, William T Johnson, Santosha A Vardhana, Maria Arcila, Steven M Horwitz, Andriy Derkach, Ahmet Dogan, Wenbin Xiao
Somatic mutations in FAS pathway increase hemophagocytic lymphohistiocytosis risk in patients with T- and/or NK-cell lymphoma. Blood advances 8 (12) (2024)
Colleen Isabelle, William T Johnson, Kathleen McConnell, Ashley Vogel, Jonathan E Brammer, Amy Boles, Robyn Keller, Paola Sindaco, Liam Nisenfeld, Guldeep Uppal, Neda Nikbakht, Bruno Calabretta, Patrizia Porazzi, Jerald Z Gong, Nitin Chakravarti, Pierluigi Porcu, Anjali Mishra
Preclinical evaluation of anti-CD38 therapy in mature T-cell neoplasms. Blood advances (2023)
Robert N Stuver, Esther Drill, David Qualls, Michelle Okwali, Connie Lee Batlevi, Philip C Caron, Ahmet Dogan, Zachary D Epstein-Peterson, Lorenzo Falchi, Paul A Hamlin, Steven M Horwitz, Brandon S Imber, Andrew M Intlekofer, William T Johnson, Niloufer Khan, Anita Kumar, Oscar B Lahoud, Jennifer Kimberly Lue, Matthew J Matasar, Alison J Moskowitz, Ariela Noy, Colette N Owens, M Lia Palomba, Heiko Schöder, Santosha A Vardhana, Joachim Yahalom, Andrew D Zelenetz, Gilles Andre Salles, David J Straus
Retrospective Characterization of Nodal Marginal Zone Lymphoma. Blood advances (2023)
William T Johnson, Nivetha Ganesan, Zachary D Epstein-Peterson, Alison J Moskowitz, Robert N Stuver, Catherine R Maccaro, Natasha Galasso, Tiffany Chang, Niloufer Khan, Umut Aypar, Natasha E Lewis, Andrew D Zelenetz, M Lia Palomba, Matthew J Matasar, Ariela Noy, Audrey M Hamilton, Paul A Hamlin, Philip C Caron, David J Straus, Andrew M Intlekofer, Connie Lee Batlevi, Anita Kumar, Colette N Owens, Craig S Sauter, Lorenzo Falchi, Jennifer K Lue, Santosha A Vardhana, Gilles Andre Salles, Ahmet Dogan, Nikolaus D Schultz, Maria E Arcila, Steven M Horwitz
TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy. Blood advances (2023)
William T Johnson, Saritha Kartan, Kelsey Sokol, Neda Nikbakht, Pierluigi Porcu
Clinical characteristics and outcomes of black patients with mycosis fungoides and Sézary syndrome: a subgroup analysis of the phase III MAVORIC trial. Leukemia & lymphoma 62 (8) (2021)
Alison J Moskowitz, Gunjan Shah, Heiko Schöder, Nivetha Ganesan, Esther Drill, Helen Hancock, Theresa Davey, Leslie Perez, Sunyoung Ryu, Samia Sohail, Alayna Santarosa, Natasha Galasso, Rachel Neuman, Brielle Liotta, William Blouin, Anita Kumar, Oscar B Lahoud, Connie Lee Batlevi, Paul Hamlin, David J Straus, Ildefonso Rodriguez-Rivera, Colette Owens, Philip Caron, Andrew M Intlekofer, Audrey Hamilton, Steven M Horwitz, Lorenzo Falchi, Erel Joffe, William T Johnson, Christina Lee, Maria Lia Palomba, Ariela Noy, Matthew J Matasar, Georgios Pongas, Gilles Andre Salles, Santosha A Vardhana, Beatriz Wills Sanin, Gottfried von Keudell, Joachim Yahalom, Ahmet Dogan, Andrew D Zelenetz, Craig H Moskowitz
Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (28) (2021)